12:00 AM
Nov 25, 2013
 |  BioCentury  |  Finance

Asian angels

New angel group BioPacific looking for Asian cross-border investments

BioPacific Investorsis looking to inject angel capital into U.S. and European life sciences companies that have a presence in Asia, or aspire to be on the ground there.

Co-founders Greg Scott and Ann Grady are no strangers to angel investing. In 2005, the pair co-founded Life Science Angels Inc., which focuses on opportunities in biotech and medical devices.

Grady is managing director of BioPacific and the group's only paid employee.

Scott went to China in 2006 as an angel investor, and for the past seven years the country has been his home base.

He is co-founder of ChinaBio LLC, a Shanghai consulting firm focused on biotech, device and diagnostic companies; organizing industry conferences, and publishing the daily newsletter ChinaBio Today.

Scott initially thought he could form an angel group in China, but found most high-net worth individuals there didn't have experience in life sciences and were uncomfortable with the risk and lengthy timelines for returns.


Read the full 769 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >